The Rising portfolio covers a broad range of trusted medications for a wide variety of treatments. We’re always looking ahead to continue providing new and affordable generic medications of the highest quality to serve our customers needs.
Late stage pipeline
Near term launch
112 product families and 19 pipeline products expected to launch in the next 12 months.
441 SKUs generating 4.5 billion doses per year.
Large and broad position in solid oral dosage products as well as a strong position in topicals and oral liquids.